Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2551-2559

  Gray, Christian P ^a   Arosio, Paolo ^b   Hersey, Peter ^a,c  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CD69 ANTIGEN; FERRITIN; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE COUNT; MALE; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITINS; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TIME FACTORS;

EID: 0038155128     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hann, H., Levy, H. M., and Evans, A. E. Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res., 40: 1413, 1980.
2. Arosio, P., Adelman, T. G., and Drysdale, J. W. On ferritin heterogeneity: further evidence for heteropolymers. J. Biol. Chem., 253: 4451-4458, 1979,
3. Theil, E. C. ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu. Rev. Biochem., 56: 285-315, 1987.
4. Morikawa, K., Oseko, F., and Morikawa, S. A role for ferritin in hematopoiesis and the immune system. Leuk. Lymphoma, 18: 429-433, 1995.
5. Hazard, J. T., and Drysdale, J. W. ferritinaemia in cancer. Nature (Lond.), 265: 755-756, 1977.
6. Constanzo, F., Colombo, M., Staempfli, S., Santoro, C., Marone, M., Frank, R., Delius, H., and Cortese, R. Structure of gene and pseudogenes of human apoferritin H. Nucleic Acids Res., 14: 721-736, 1986.
7. Addison, G. M., Beamish, M. R., Hales, C. N., Hodgkins, M., Jacobs, A., and Llewellin, P. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J. Clin. Pathol., 25: 326-329, 1972.
8. Lipschitz, D. A., Allegre, A., and Cook, J. D. The clinical significance of ferritinuria. Blood, 55: 260-264, 1980.
9. Hallegren, R., Terent, A., Bergstrom, K., and Birgegard, G. Cerbrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol. Scand., 61: 384-392, 1980.
10. Klockars, M., Weber, T., Tanner, P., Hellstrom, P. E., and Petterson, T. Pleural fluid ferritin concentrations in human disease. J. Clin. Pathol., 38: 818-824, 1985.
11. Arosio, P., Ferrero, R., and Ponzone, A. ferritin in human milk. Acta Paediatr. Scand., 73: 271-272, 1984.
12. Ruggeri, G., Iacobello, C., Albertini, A., Brocchi, E., Levi, S., Gabri, E., and Arosio, P. Studies of human ferritin in tissues and body fluids. In: A. Albertini (ed.), Ferritins and Isoferritins as Biochemical Markers, pp. 67-78. Amsterdam: Elsevier, 1984.
13. Broxmeyer, H. E., Gentile, P., Bognaki, H., and Ralph, P. Lactoferritin, transferrin, and acidic isoferritins: regulatory molecules with potential therapeutic value in leukemia. Blood Cells (NY), 9: 83-105, 1983.
14. De Sousa, M., Smithyman, A., and Tan, C. Suggested models of ecotaxopathy in lymphoreticular malignancy: role of iron binding proteins in control of lymphoid cell migration. Am. J. Pathol., 90: 497-510, 1978.
15. Hangcock, S. W., Bruce, L., and May, K. ferritin: a sensitizing substance in leucocyte migration inhibition test in patients with malignant lymphoma. Br. J. Haematol., 43: 229-233, 1979.
16. Finch, C. A., and Huebers, H. A. Perspectives in iron metabolism. N. Eng. J. Med., 306: 1520-1528, 1982.
17. Lipschitz, D. A., Cook, J. D., and Finch, C. A. A clinical evaluation of serum ferritin as an index of iron stores. N. Eng. J. Med., 290: 1213-1216, 1974.
18. Iancu, T. C., Shiloh, H., and Kedar, A. Neuroblastomas contain iron-rich ferritin. Cancer (Phila.), 61: 2497-2502, 1988.
19. Luger, T. A., Linkesch, W., Knobler, R., and Kokoschka, E. M. Serial determination of serum ferritin levels in patients with malignant melanoma. Oncology, 40: 263-267, 1983.
20. Partin, A. W., Criley, S. R., Steiner, M. S., Hsieh, K., Simons, J. W., Lumadue, J., Carter, H. B., and Marshall, F. F. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology, 45: 211-217, 1995.
21. Gray, C. P., Franco, A. V., Arosio, P., and Hersey, P. Immunosuppressive effects of melanoma-derived heavy-chain ferritinare dependent on stimulation of IL-10 production. Int. J. Cancer, 92: 843-850, 2001.
22. Gray, C. P., Arosio, P., and Hersey, P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood, 99: 3326-3334, 2002.
23. + T cells with immunoregulatory properties. Allergy Clin. Immunol., 106: S109-S112, 2000.
24. Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter, L. W., and Akbar, A. N. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol., 31: 1122-1131, 2001.
25. Chen, W., Jin, W., and Wahl, S. M. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells. J. Exp. Med., 188: 1849-1857, 1998.
26. Read, S., Malmstrom, V., and Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med., 192: 295-302, 2000.
27. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., and Sakaguchi, S. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med., 192: 303-309, 2000.
28. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (Lond.), 389: 737-742, 1997.
29. Han, H. S., Jun, H. S., Utsugi, T., and Yoon, J. W. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J. Autoimmun., 9: 331-339, 1996.
30. Chen, J., Huoam, C., Plain, K., He, X. Y., Hodgkinson, S. J., and Hall, B. M. CD4(+). CD25(+) T cells as regulators of alloimmune responses. Transplant Proc., 33: 163-164, 2001.
31. Hall, B. M., Fava, L., Chen, J., Plain, K. M., Boyd, R. A., Spicer, S. T., and Berger, M. F. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4. J. Immunol., 161: 5147-5156, 1998.
32. Buer, J., Lanoue, A., Franzke, A., Garcia, C., von Boehmer, H., and Sarukhan, A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med., 187: 177-183, 1998.
33. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res., 61: 4766-4772, 2001.
34. Liyanage, U. K., Moore, T. T., Joo, H.G., Tanaka, Y., Herrmann, V., Doherty, G., Derbin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., and Linehan, D. C. Prevalence of regulatory T cells is increased in peripheral blood and tumour microenviroment of patients with pancreas or breast adenocarcinoma. J. Immunol., 169: 2756-2761, 2002.
35. Corsi, B., Perrone, F., Bourgeois, M., Beaumont, C., Panzeri, M. C., Cozzi, A., Sangregorio, R., Santambrogio, P., Albertini, A., Arosio, P., and Levi, S. Transient overexpression of human H- and L-ferritin in COS cells. J. Biol. Chem., 330: 315-320, 1998.
36. Cozzi, A., Levi, S., Bazzigaluppi, E., Ruggeri, G., and Arosio, P. Development of an immunoassay for all human isoferritins, and its application to serum ferritin evaluation. Clin. Chim. Acta, 184: 197-206, 1989.
37. Reinherz, E., and Schlossman, S. Human T-lymphocyte differentiation. Immunol. Today, 3: 239-240, 1982.
38. Levi, S., Cesareni, G., Arosio, P., Lorenzetti, R., Soria, M., Sollazzo, M., Albertini, A., and Cortese, R. Characterization of human ferritin H chain synthetized in Escherichia coli. Gene (Amst.), 51: 269-274, 1987.
39. Levi, S., Yewdall, S. J., Harrison, P. M., Santambrogio, P., Cozzi, A., Rovidia, E., Albertini, A., and Arosio, P. Evidence or H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. J. Biol. Chem., 288: 591-596, 1992.
40. Hersey, P., Bindon, C., Czerniecki, M., Spurling, A., Wass, J., and McCarthy, W. Inhibition of interleukin 2 production by factors released from tumor cells. J. Immunol., 131: 2837-2842, 1983.
41. Vaisman, B., Santambrogio, P., Arosio, P., Fibach, E., and Konijn, A. M. An ELISA for the H-subunit of human ferritin which employs a combination of rabbit poly- and mice monoclonal antibodies and an enzyme labeled anti-mouse-IgG. Clin. Chem. Lab. Med., 37: 121-125, 1999.
42. Sharrow, C. O. Analysis of flow cytometry data. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology, Suppl. 20 ed. New York: John Wiley & Sons, 1996.
43. Cazzola, M., Arosio, P., Bellotti, V., Bergamaschi, G., Dezza, L., Iacobello, C., and Ruggeri, G. Use of a monoclonal antibody against human heart ferritin evaluating acidic ferritin concentration in human serum. Br. J. Haematol., 61: 445-453, 1985.
44. Marcus, D. M., and Zinberg, N. Ferritin. In: Heberman, R., and McIntire, J. A. (eds.), Immunodiagnosis, Part 1, Vol. 9. London: 473-499. Academic Press, 1979.
45. Cox, R., Gyde, O. H., and Leyland, M. J. Serum ferritin levels in small lung cancer. Eur. J. Cancer, 22: 831-835, 1986.
46. Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., and Schuler, G. Ex vivo isolation and characterization of CD4+ CD25+ T cells with regulatory properties from human blood. J. Exp. Med., 193: 1303-1310, 2001.
47. Levings, M. K., Sangregorio, R., and Roncarolo, M.G. Human CD25+ CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med., 193: 1295-1301, 2001.
48. Ng, W. F., Duggan, P. J., Ponchel, F., Matarese, G., Lombardi, G., Edwards, A. D., Isaacs, J. D., and Lechler, R. I. Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood, 98: 2736-2744, 2001.
49. Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A., and Caton, A. J. Thymic selection of CD4+ CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol., 2: 301-306, 2001.
50. Noel, C., Florquin, S., Goldman, M., and Braun, M. Y. Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity. Int. Immunol., 13: 431-439, 2001.